About Black TriangleBT3Indica Hybrid
Black Triangle is a rare indica hybrid strain created through crossing the infamous Triangle Kush X '88 G13 Hashplant.
Black Triangle is a relatively new strain that was created by crossing the strains Triangle Kush and '88 G13 Hashplant. Both of these parent strains are highly regarded in the cannabis community for their potency and effects.
Black Triangle typically has small to medium-sized buds that are dense and compact, with a dark green color and purple hues. The buds are covered in a thick layer of resin and have a sweet and earthy aroma, with undertones of pine and spice. The flavour is similar, with a sweet and spicy taste and a hint of earthy pine.
Black Triangle can be grown indoors or outdoors, but it requires a warm and dry climate with plenty of light and good air circulation. It has a flowering time of around 8-9 weeks and can yield moderate to high amounts of buds.
Description provided by Wikileaf.
Information provided could come from a third-party source, and likely does not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).
About Cannim Australia Pty Ltd
We are a leading global cannabis company providing GACP and GMP certified medical solutions to deliver better physical and mental health outcomes for patients around the world.
Pioneering better health outcomes for those in need by harnessing the power of therapeutic cannabis.
Based in Sydney, Australia, Cannim was established in 2017 to bring the benefits of medicinal cannabis to the world.
Back in 2017, Cannabis was still stigmatised and cultivation considered an art form. Built on the 3 core pillars of Safety, Science, and Scale, Cannim established an organisation that could show people that Cannabis was a real medicine, consistently develop it to pharmaceutical standards, and establish networks to reach a wide audience of needy people.
Just 4 years later, Cannim cultivates in Jamaica and Australia, and established a network of EU GMP manufacturers as well as formed alliances in education and healthcare, offering products & services to bring relief in many forms to people across the world.
This industry is nascent and this is only the beginning of the journey to establish Cannabis as a reputable medicine around the world. Cannim continues to create scale in its operations, giving us the ability to meet the needs of the ever-growing body of medicinal cannabis users. Cannim is pioneering the development of the category, creating new ways of administration for patients, leading research and education into the effects of cannabis on a variety of conditions, pioneering its usefulness for others, and ensuring those in need get what they need when they need it at a price that's fair.cannim.com